6 European Projects Found
Searched on 125080 European Projects
FINISHED
New siRNA Nanotherapy for Inflammatory Bowel Diseases, targeting Janus kinase 3 (NEW DEAL)
Start date: Feb 1, 2017, End date: Jan 31, 2021,
Inflammatory bowel diseases (IBD) are the second most common immune-mediated disorders in Europe, affecting more particularly young people. The current therapies, including antibodies, show three main drawbacks: efficacy, tolerability and convenience. NEW DEAL solution will offer radical therapeutic progress for all IBD patients, thanks to the improved efficacy and increased safety of the specific ...
Read Project
11
Partners Participants
FINISHED
NOVEL, SUSTAINABLE MARINE BIO-SURFACTANT / BIO-EMULSIFIERS FOR COMMERCIAL EXPLOITATION (MARISURF)
Start date: Sep 1, 2015, End date: Aug 31, 2020,
Surfactants and emulsifiers constitute an important class of chemical agents that are widely used in almost every sector of modern industry. The huge market demand is currently met almost exclusively by synthetic, mainly petroleum-based, chemical products, which are usually non-biodegradable and mostly toxic or GM plant based products (used in foods), which are undesirable by some end-users. Their ...
Read Project
13
Partners Participants
FINISHED
BIOactive implantable CApsule for PANcreatic islets immunosuppression free therapy (BIOCAPAN)
Start date: Jun 1, 2015, End date: May 31, 2019,
The key therapeutic issue in diabetes mellitus type I and II is glycaemic control. Reductions of constant self-control, of insulin injections, and of long-term complications would have tremendous benefit for quality of life. The best therapy option is the transplantation of allogeneic islet cells, but the current state of the art limits the applicability of this approach. Implanting unprotected gr ...
Read Project
10
Partners Participants
FINISHED
Lab-on-a-chip microfluidic device based on plasmonic driven thermal nanobiosensing for rapid detection of Salmonella in chicken meat. (HEATSENS_S)
Start date: Sep 1, 2016, End date: Feb 28, 2018,
NANOIMMUNOTECH (NIT) is a nanobiotechnology Company which is the sole exploiter of an exclusive ultrasensitive biosensor nanotechnology, called HEATSENS. Thanks to the innovation of using gold nanoprisms, it is able to detect analytes with a low level of detection (attomolar detection limit, one million times more sensitive than competitors), in a faster, cheaper and simpler way than current metho ...
Read Project
1
Partner Participant
FINISHED
Nanotherapeutics for antibiotic resistant emerging bacterial pathogens (NAREB)
Start date: Feb 1, 2014, End date: Jan 31, 2018,
Increase in antibiotic resistance is a global concern worldwide. The project NAREB's main objective is the optimization of several nanoformulations of antibacterial therapeutics in order to improve the therapy of multi-drug resistant (MDR) tuberculosis (TB) and MRSA infections in European MDR patients.NAREB will address the problem of drug bioavailability inside the infected macrophages, transport ...
Read Project
16
Partners Participants
FINISHED
Lab-on-a-chip microfluidic device based on plasmonicdriven thermal sensing for rapid detection of Salmonella typhimurium in agro-food field. (HEATSENS_S)
Start date: May 1, 2015, End date: Oct 31, 2015,
NANOIMMUNOTECH (NIT), a leading company in nanobiotechnology with know-how that has been applied to the field of nanobiosensing and especially the agro-food sector introduces HEATSENS in the poultry industry: a solution that transforms into a portable and easy-to-use device with its most cutting-edge know-how in biosensors. HEATSENS is based on a revolutionary nanobiosensing technology owned by th ...
Read Project
